Histological classification and stage of newly diagnosed bladder cancer in a population-based study from the Northeastern United States

References

• Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin 2006; 56: 106–30
   PubMed Web of Science ®Google Scholar
• Hartge P, Silverman DT, Schairer C, Hoover RN. Smoking and bladder cancer risk in blacks and whites in the United States. Cancer Causes Control 1993; 4: 391–4
   PubMed Web of Science ®Google Scholar
• Silverman DT, Levin LI, Hoover RN. Occupational risks of bladder cancer in the United States: II. Nonwhite men. J Natl Cancer Inst 1989; 81: 1480–3
   PubMedGoogle Scholar
• Silverman DT, Levin LI, Hoover RN. Occupational risks of bladder cancer among white women in the United States. Am J Epidemiol 1990; 132: 453–61
   PubMed Web of Science ®Google Scholar
• Silverman DT, Hartge P, Morrison AS, Devesa SS. Epidemiology of bladder cancer. Hematol Oncol Clin North Am 1992; 6: 1–30
   PubMed Web of Science ®Google Scholar
• Silverman DT, Morrison AS, Devesa SS. Bladder cancer. In: David Schottenfeld, Joseph F. Fraumeni, Jr Cancer epidemiology and prevention, 2nd ed. New York: Oxford University Press; 1996. p 1156–79.
   Google Scholar
• Soloway MS, Bruck DS, Kim SS. Expectant management of small, recurrent, noninvasive papillary bladder tumors. J Urol 2003; 170: 438–41
   PubMed Web of Science ®Google Scholar
• Lutzeyer W, Rubben H, Dahm H. Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. J Urol 1982; 127: 250–2
   PubMed Web of Science ®Google Scholar
• Heney N, Proppe K, Prout GR, Jr, Griffin PP, Shipley WU. Invasive bladder cancer: tumor configuration, lymphatic invasion, and survival. J Urol 1983; 130: 1083–7
   PubMed Web of Science ®Google Scholar
• Takashi M, Murase T, Mizuno S, Hamajima N, Ohno Y. Multivariate evaluation of prognostic determinants in bladder cancer patients. Urol Int 1987; 42: 368–74
   PubMed Web of Science ®Google Scholar
• Kiemeney L, Witjes JA, Heijbroek RP, Verbeek AL, Debruyne FM. Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer. J Urol 1993; 150: 60–4
   PubMed Web of Science ®Google Scholar
• Holmäng S, Hedelin H, Anderstrom C, Johannson SL. The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. J Urol 1995; 153: 1823–7
   PubMed Web of Science ®Google Scholar
• Pauwels RPE, Schapers RFM, Smeets AWGB, Debruyne FMJ, Geraedts JPM. Grading in superficial bladder cancer. (1) Morphological criteria. Br J Urol 1988; 61: 129–34
   PubMedGoogle Scholar
• Holmäng S, Hedelin H, Anderström C, Holmberg E, Johansson SL. Prospective registration of all patients in a geographical region with newly diagnosed bladder carcinomas during a two-year period. Scand J Urol Nephrol 2000; 34: 95–101
   PubMed Web of Science ®Google Scholar
• Larsson P, Wijkstrom H, Thorstenson A, Adolfsson J, Norming U, Wiklund P, et al. A population-based study of 538 patients with newly detected urinary bladder neoplasms followed during 5 years. Scand J Urol Nephrol 2003; 37: 195–201
   PubMed Web of Science ®Google Scholar
• Karagas MR, Tosteson TD, Blum J, Morris JS, Baron JA, Klaue B. Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a US population. Environ Health Perspect 1998; 106(Suppl 4)1047–50
   PubMedGoogle Scholar
• Mostofi FK, Sobin LH, Torloni H. Histological typing of urinary bladder tumours. International histological classification of tumours, No. 10. World Health Organization, Geneva 1973
   Google Scholar
• Epstein JI, Amin MB, Reuter VR, Bladder Consensus Conference Committee. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 1998;22:1435–48.
   PubMed Web of Science ®Google Scholar
• Eble JN, Sauter G, Epstein JI, Sesterhenn IA. World Health Organization classification of tumours. Pathology and genetics. Tumours of the urinary system and male genital organs. IARC Press, Lyon 2004
   Google Scholar
• Sobin LH, Wittekind C. UICC TNM classification of malignant tumours6th ed. Wiley-Liss, New York 2002
   Google Scholar
• Wolf H, Olsen PR, Fischer A, Højgaard K. Urothelial atypia concomitant with primary bladder tumour: incidence in a consecutive series of 500 unselected patients. Scand J Urol Nephrol 1987; 21: 33–8
   PubMed Web of Science ®Google Scholar
• Fosså SD, Ous S, Espetveit S, Langmark F. Patterns of primary care and survival in 336 consecutive unselected Norwegian patients with bladder cancer. Scand J Urol Nephrol 1992; 26: 131–8
   PubMed Web of Science ®Google Scholar
• Oosterhuis JWA, Schapers RFM, Janssen-Heijen MLG, Pauwels RP, Newling DW, ten Kate F. Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems. J Clin Pathol 2002; 55: 900–5
   PubMed Web of Science ®Google Scholar
• Samaratunga H, Makarov DV, Epstein JI. Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression. Urology 2002; 60: 315–9
   PubMed Web of Science ®Google Scholar
• Yin H, Leong AS-Y. Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up. Am J Clin Pathol 2004; 121: 679–87
   PubMed Web of Science ®Google Scholar
• Cheng L, Neumann RM, Nehra A, Spotts BE, Weaver AL, Bostwick DG. Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma. Cancer 2000; 88: 1663–70
   PubMed Web of Science ®Google Scholar
• Lipponen PK, Eskelinen M, Jauhiainen K, Terho R, Harju E. Clinical prognostic factors in transitional cell cancer of the bladder. Urol Int 1993; 50: 192–7
   PubMed Web of Science ®Google Scholar
• Holmäng S, Andius P, Hedelin H, Wester K, Busch C, Johansson SL. Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy. J Urol 2001; 165: 1124–30
   PubMed Web of Science ®Google Scholar
• Karagas MR, Tosteson TD, Morris JS, Demidenko E, Mott LA, Heaney J, et al. Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire. Cancer Causes Control 2004; 15: 465–72
   PubMed Web of Science ®Google Scholar